Endothelin A Receptor/β-Arrestin Signaling to the Wnt Pathway Renders Ovarian Cancer Cells Resistant to Chemotherapy

Wnt信号通路 癌症研究 生物 卵巢癌 信号转导 内科学 癌症 医学 细胞生物学 遗传学
作者
Laura Rosanò,Roberta Cianfrocca,Piera Tocci,Francesca Spinella,Valeriana Di Castro,Valentina Caprara,Elisa Semprucci,Gabriella Ferrandina,Pier Giorgio Natali,Anna Bagnato
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:74 (24): 7453-7464 被引量:107
标识
DOI:10.1158/0008-5472.can-13-3133
摘要

The high mortality of epithelial ovarian cancer (EOC) is mainly caused by resistance to the available therapies. In EOC, the endothelin-1 (ET-1, EDN1)-endothelin A receptor (ETAR, EDNRA) signaling axis regulates the epithelial-mesenchymal transition (EMT) and a chemoresistant phenotype. However, there is a paucity of knowledge about how ET-1 mediates drug resistance. Here, we define a novel bypass mechanism through which ETAR/β-arrestin-1 (β-arr1, ARRB1) links Wnt signaling to acquire chemoresistant and EMT phenotype. We found that ETAR/β-arr1 activity promoted nuclear complex with β-catenin and p300, resulting in histone acetylation, chromatin reorganization, and enhanced transcription of genes, such as ET-1, enhancing the network that sustains chemoresistance. Silencing of β-arr1 or pharmacologic treatment with the dual ETAR/ETBR antagonist macitentan prevented core complex formation and restored drug sensitivity, impairing the signaling pathways involved in cell survival, EMT, and invasion. In vivo macitentan treatment reduced tumor growth, vascularization, intravasation, and metastatic progression. The combination of macitentan and cisplatinum resulted in the potentiation of the cytotoxic effect, indicating that macitentan can enhance sensitivity to chemotherapy. Investigations in clinical specimens of chemoresistant EOC tissues confirmed increased recruitment of β-arr1 and β-catenin to ET-1 gene promoter. In these tissues, high expression of ETAR significantly associated with poor clinical outcome and chemoresistance. Collectively, our findings reveal the existence of a novel mechanism by which ETAR/β-arr1 signaling is integrated with the Wnt/β-catenin pathway to sustain chemoresistance in EOC, and they offer a solid rationale for clinical evaluation of macitentan in combination with chemotherapy to overcome chemoresistance in this setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
结实的水蓉完成签到,获得积分10
刚刚
2361760724完成签到,获得积分10
刚刚
还真不错发布了新的文献求助10
1秒前
OoO发布了新的文献求助10
1秒前
hsssy完成签到,获得积分10
1秒前
Jasper的应助被riooo采纳,获得10
1秒前
研友_VZG7GZ的应助被杨敏采纳,获得10
2秒前
虚心的渊思完成签到,获得积分10
2秒前
2秒前
元吉的应助被LQ采纳,获得10
2秒前
深情安青的应助被Shu舒采纳,获得10
2秒前
踏实的老四完成签到,获得积分10
2秒前
隐形羽毛完成签到,获得积分10
2秒前
桐桐的应助被漫漫采纳,获得10
2秒前
3秒前
SZZ完成签到,获得积分10
3秒前
3秒前
喵喵喵发布了新的文献求助10
3秒前
打打的应助被今天看文献了吗采纳,获得10
3秒前
3秒前
野性的发卡完成签到,获得积分10
3秒前
我是谁的应助被Tongtong采纳,获得10
4秒前
英俊的铭的应助被炫彩小陈采纳,获得10
4秒前
4秒前
4秒前
明理的千筹发布了新的文献求助100
5秒前
5秒前
文思发布了新的文献求助10
5秒前
hhdr完成签到 ,获得积分10
5秒前
hua完成签到 ,获得积分10
5秒前
Akim的应助被王梦姣采纳,获得10
5秒前
dd发布了新的文献求助10
5秒前
情怀的应助被美好的千凝采纳,获得10
6秒前
丫丫完成签到,获得积分10
6秒前
年轻冰夏完成签到,获得积分10
6秒前
7秒前
端庄醉山发布了新的文献求助10
7秒前
凤族无双发布了新的文献求助10
7秒前
派大星完成签到,获得积分20
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346